Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. Several investigators have reported that the efficacy of 5HT3 receptor antagonists is maintained over repeated ...
For patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia (CML), the use of the BCR–ABL1 tyrosine kinase inhibitor (TKI) imatinib led to 8-year overall survival (OS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results